24370-84-1

Basic information

• Product Name: Butanoic acid, 3-oxo-, 2-phenylethyl ester
• CAS NO: 24370-84-1
• Molecular Formula: C12H14O3
• Molecular Weight: 206.241
• Mol File: 24370-84-1.mol
• Article Data: 16

Chemical Properties

• CAS DataBase Reference: Butanoic acid, 3-oxo-, 2-phenylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Butanoic acid, 3-oxo-, 2-phenylethyl ester(24370-84-1)
• EPA Substance Registry System: Butanoic acid, 3-oxo-, 2-phenylethyl ester(24370-84-1)

Safety Data

• Hazardous Substances Data: 24370-84-1(Hazardous Substances Data)

Upstream product

• 60-12-8 2-phenylethanol 
• 105-45-3 acetoacetic acid methyl ester 
• 1694-31-1 tert-butyl acetoacetate 
• 42490-66-4 2,2,6-trimethyl-4H-1,3-dioxin-4-one 
• 5394-63-8 2,2,6-trimethyl-4H-1,3-dioxin-4-one 
• 122-97-4 3-Phenyl-1-propanol 
• 674-82-8 4-methyleneoxetan-2-one 
• 103-45-7 acetic acid phenethyl ester 

Downstream Products

• 146072-74-4 2-phenyl-1-ethyl diazoacetoacetate 
• 100287-71-6 2-[1-(2-Nitro-phenyl)-meth-(E)-ylidene]-3-oxo-butyric acid phenethyl ester 
• 1342885-01-1 di(phenethyl) 4-(5-chloro-1H-imidazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate 
• 1342885-01-1 di(phenethyl) 4-(4-chloro-1H-imidazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate 
• 49679-97-2 2-phenylethyl 3-amino-2-butenoate 
• 1000684-25-2 ethyl phenethyl 1,4-dihydro-2,6-dimethyl-4-(1-methyl-4,5-dichloroimidazole-2-yl)-3,5-pyridine dicarboxylate 
• 118431-38-2 1,6-Dimethyl-4-(2-nitro-phenyl)-3-thiophen-2-yl-4,7-dihydro-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid phenethyl ester 

Relevant articles and documents

NEW ANALOGS AS ANDROGEN RECEPTOR AND GLUCOCORTICOID RECEPTOR MODULATORS

The present invention relates to novel dihydropyridine derivatives of formula (I): as modulators of nuclear receptors selected from androgen receptor and glucocorticoid receptor, to processes for their preparation, to pharmaceutical compositions comprising said compounds and to the use of said for manufacturing a medicament for the treatment of pathological conditions or diseases that can improve by modulation of androgen receptor and/or glucocorticoid receptor, selected from cancer, metastasizing cancers, benign prostate hyperplasia, polycystic ovary syndrome (PCOS), hair loss, hirsutism, acne, hypogonadism, muscle wasting diseases, cachexia, Cushing's syndrome, anti-psychotic drug induced weight gain, obesity, post-traumatic stress disorder and alcoholism.

An efficient synthesis of β-ketoesters via transesterification and its application in Biginelli reaction under solvent-free, catalyst-free conditions

A simple and efficient transesterification process for the synthesis of β-ketoester derivatives has been achieved by the reaction of methyl β-ketoester with higher alcohols at 110 C under solvent-free, catalyst-free conditions and its application in synthesis of 3,4-dihydropyrimidin-2(1H)-ones C-5 ester derivatives via Biginelli reaction has been described.

Efficient trans-acetoacylation mediated by ytterbium(III) triflate as a catalyst under solvent-free condition

A simple and efficient trans-acetoacylation method for the synthesis of β-keto ester derivatives has been described using ytterbium(III) triflate as a new catalyst under solvent-free condition. This method was found to be efficient and convenient for the synthesis of a wide variety of β-keto ester derivatives.